Response to Neoadjuvant Systemic Therapy for Breast Cancer in BRCA Mutation Carriers and Noncarriers: A Single-Institution Experience

PURPOSE: To compare the pathologic complete response (pCR) rate and relapse-free survival (RFS) and overall survival (OS) after neoadjuvant systemic chemotherapy (NST) in patients with breast cancer with and without deleterious BRCA1 and BRCA2 mutations. PATIENTS AND METHODS: A total of 317 women wh...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Arun, Banu, Bayraktar, Soley, Liu, Diane D., Gutierrez Barrera, Angelica M., Atchley, Deann, Pusztai, Lajos, Litton, Jennifer Keating, Valero, Vicente, Meric-Bernstam, Funda, Hortobagyi, Gabriel N., Albarracin, Constance
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2011
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4874218/
https://ncbi.nlm.nih.gov/pubmed/21900106
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.35.2682
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados